Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease: A Review of Existing Literature and Best Practices

por Bhat, Shubha, Qazi, Taha
Publicado 2021

Cryptogenic Multifocal Ulcerative Sclerosing Enteritis: A Curious Case of Intestinal Obstruction in the Setting of Human Immunodeficiency Virus

por Hathorn, Kelly, Qazi, Taha, Caton, Michael Travis, Allegretti, Jessica R.
Publicado 2019

Prevalence of Obstructive Sleep Apnea Is Increased in Patients With Inflammatory Bowel Disease: A Large, Multi-Network Study

por Hoffman, Kyle, Mansoor, Emad, Panhwar, Muhammad Siyab, Regueiro, Miguel, Cooper, Gregory, Qazi, Taha
Publicado 2022

Biomarkers for the Evaluation of Pouch Inflammation: A Systematic Review

por Falloon, Katherine, Cohen, Benjamin L, Ottichilo, Ronald, Grove, David, Rieder, Florian, Qazi, Taha
Publicado 2022

Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb

por Bhat, Shubha, Altajar, Sarah, Shankar, Divya, Zahorian, Toni, Robert, Regine, Qazi, Taha, Shah, Bhavesh, Farraye, Francis A.
Publicado 2020

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme

por Farraye, Francis A., Qazi, Taha, Kotze, Paulo G., Moore, Gregory T., Mundayat, Rajiv, Lawendy, Nervin, Sharma, Puza P., Judd, Donna T.
Publicado 2021

Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease

por El Ouali, Sara, Baker, Mark E., Lyu, Ruishen, Fletcher, Joel G., Bruining, David H., Holubar, Stefan D., Click, Benjamin, Qazi, Taha, Cohen, Benjamin L., Rieder, Florian
Publicado 2022